Medical/Pharmaceuticals
Nutromics raises US$14 million for its ground-breaking wearable diagnostic platform
MELBOURNE, Australia and SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Global MedTech start-up Nutromics has raised an additional US$14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics' continued expansion acrossAustralia and the United States. Strategic in...
2022-09-08 20:54
2187
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting
SHANGHAI, Sept. 8, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally
recognized OTM innovative platform, today announced that it has successfully
concluded the first Steering Committee meeting for PADN Global Clinical Trial.
2022-09-08 20:30
1220
Hummingbird Bioscience Announces Trial in Progress Poster Presentation at the European Society for Medical Oncology Congress 2022
* HMBD-001 is a proprietary anti-HER3 antibody in an ongoing Phase 1 trial targeting multiple solid tumors * HMBD-001 has the potential to fully block both ligand-dependent and -independent HER3 signaling SINGAPORE, Sept. 8, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision...
2022-09-08 20:00
1744
ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
* International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics * The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the ...
2022-09-08 16:41
1450
NeuroXess Attends WAIC with its First Medical-Grade BCI Product Pipeline
SHANGHAI, Sept. 8, 2022 /PRNewswire/ -- The Brain Sciences Theme Forum of 2022 World Artificial Intelligence Conference (WAIC) was held at Shanghai World Exhibition and Convention Center onSeptember 2. NeuroXess, a China-based high-tech life science company focusing on flexible electrode BCI (br...
2022-09-08 16:19
1429
Cytiva launches BioChallenge in Southeast Asia to support biotech startup development
* Cytiva's BioChallenge launches in Singapore, Indonesia, Thailand and Vietnam to accelerate the growth of promising emerging biotechs * BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market * Application pe...
2022-09-08 15:31
2211
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies
Innovations triggered by the pandemic are pushing industries to adopt long-lasting antimicrobial technology, says Frost & Sullivan SAN ANTONIO, Sept. 8, 2022 /PRNewswire/ -- The outbreak of COVID-19 unlocked the demand for antimicrobial technologies across sectors, finds Frost & Sullivan's recen...
2022-09-08 15:12
1584
Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study
ROCKVILLE, Md. and SUZHOU, China, Sept. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology...
2022-09-08 08:05
3050
InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer
NANJING, China, Sept. 7, 2022 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicates to developing innovative therapies targeting drug resistance and metastasis for hard-to-treat solid tumors, today announced the dosing of the first patient in its Phase 2 pivotal study ...
2022-09-08 08:00
1544
Sangel Capital Founder Receives Title of China's Top Early-Stage Investor from ChinaVenture Awards
SHENZHEN, China, Sept. 7, 2022 /PRNewswire/ -- Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, has announced that Liu Mulong, Founding Partner with the Company, has been awarded as one ofChina's top early-stage investors of 2021 ...
2022-09-07 23:30
3161
Global study shows Artificial Intelligence can reduce time to pregnancy for IVF couples by 12%
SAN FRANCISCO, Sept. 7, 2022 /PRNewswire/ -- Reproductive BioMedicine Online (RBMO) journal has published results of an international clinical study BY Presagen showing that its Artificial Intelligence (AI) product Life Whisperer can reduce time to pregnancy for IVF couples by 12%, potentially sa...
2022-09-07 21:07
2364
Biosion, Inc. Appoints Dr. Rakesh Dixit, ADC Thought Leader, to Advisory Board
NEWARK, Del., Sept. 7, 2022 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a global R&D biotechnology company, today announced the appointment ofRakesh Dixit , Ph.D., DABT to its Advisory Board to advance Antibody Drug-Conjugates (ADCs) for the treatment of solid tumor cancers in Biosion's pipeline. ...
2022-09-07 20:54
2772
Pulnovo Medical Limited's PADN Technology Included in 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH
SHANGHAI, Sept. 7, 2022 /PRNewswire/ -- A globally recognized OTM innovative
platform Pulnovo Medical
2022-09-07 20:30
2821
Lianhua Products Designated as Epidemic Prevention Supplies : 2022 CIFTIS
SHIJIAZHUANG, China, Sept. 7, 2022 /PRNewswire/ -- The 2022 China International Fair for Trade in Services (CIFTIS), which opened onAugust 31, 2022, in Beijing , is the only annual international and comprehensive platform for trade in services in the world. Yiling Pharmaceutical's Lianhua respirat...
2022-09-07 20:15
3048
GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting
SHANGHAI and PARIS, Sept. 7, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH018 (TGF-β R1 inhibitor) monotherapy (NCT05051241) for treatment of a...
2022-09-07 19:00
2537
Australian company developing cutting edge training for Defence medics using virtual reality and biometrics
MELBOURNE, Australia, Sept. 7, 2022 /PRNewswire/ -- Australian first responder training company Real Response has created breakthrough software with support from Defence to enhance tactical and combat medical training. The system uses virtual reality and live biometric data to provide medics with...
2022-09-07 16:15
3445
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action
VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus (African a...
2022-09-07 14:32
2621
Prolonging healthspan by delaying ageing -- NUHS opens Singapore's first Centre for Healthy Longevity to increase healthy lifespan of Singapore population by five more disease-free years
The National University Health System (NUHS) establishes the NUHS Centre for
Healthy Longevity
2022-09-07 13:00
3451
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
GAITHERSBURG, Md. and SUZHOU, China, Sept. 7, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dr.Patrick Lu, PhD, founder, Chairman of the Board, ...
2022-09-07 11:32
2992
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds
MILAN, Sept. 7, 2022 /PRNewswire/ -- Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of paediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown. The Barrie...
2022-09-07 06:01
3240
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
